GlaxoSmithKline, LLC recalls Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhale…
- Recall date
- March 22, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0626-2017
- FDA classification
- Class II
- Brand / firm
- GlaxoSmithKline, LLC
- Sold / distributed
- Nationwide in the USA and Puerto Rico
Why it was recalled
Defective Delivery System: Elevated number of units with out of specification results for leak rate.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 Metered Inhalations, Net Wt. 18 g inhalers, Rx only, GlaxoSmithKline, Research Triangle Park, NC 22709, NDC 0173-0682-20.
Get recall alerts
Free email alert whenever GlaxoSmithKline, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: GlaxoSmithKline, LLC